Patrick Lamy, Senior VP, Commercial Strategy at Akero Therapeutics, Inc. (AKRO), sold 2,000 shares at $53.82 ($108K) on 2025-06-16, disclosed to the SEC on 2025-06-20.
Scheduled sale ($108k) by Senior VP, Commercial Strategy under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.82 | 1,500 | $81K | 74.6% |
| 2 | $55.09 | 500 | $28K | 25.4% |
| Total | $54.14 avg | 2,000 | $108K | 100% |
| Filing → |
| AKRO | SELL | 2025-06-12 | $50K | — | Filing → |
| AKRO | SELL | 2025-06-04 | $201K | — | Filing → |
| AKRO | SELL | 2025-05-23 | $200K | — | Filing → |